Furthermore, sCD163 correlated with hepatic injury and metabolic dysregulation in NAFLD patients and obese individuals before and after lifestyle or surgical intervention [25,28,29]. This evidence concerns the gene CD163 and metabolic dysfunction-associated steatotic liver disease.